Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 10, 2011 - Issue 3
Submit an article Journal homepage
465
Views
42
CrossRef citations to date
0
Altmetric
Reviews

The safety of thiazolidinediones

Keith G TolmanUniversity of Utah College of Pharmacy, Department of Pharmacology and Toxicology, 4059 S. Gary Rd, SLC, UT 84124, USA+1 801 277 2770; [email protected]
, MD FACP
Pages 419-428 | Published online: 03 Mar 2011

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Zhong-Min Liu, Miao Hu, Paul Chan & Brian Tomlinson. (2015) Early investigational drugs targeting PPAR-α for the treatment of metabolic disease. Expert Opinion on Investigational Drugs 24:5, pages 611-621.
Read now
Amirhossein Sahebkar, Gerard T Chew & Gerald F Watts. (2014) New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. Expert Opinion on Pharmacotherapy 15:4, pages 493-503.
Read now
André J Scheen. (2013) Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease. Expert Opinion on Drug Metabolism & Toxicology 9:5, pages 529-550.
Read now
Michele Bortolini, Matthew B Wright, Martin Bopst & Bogdana Balas. (2013) Examining the safety of PPAR agonists – current trends and future prospects. Expert Opinion on Drug Safety 12:1, pages 65-79.
Read now

Articles from other publishers (38)

Silvia Arifi, Julian A. Marschner, Julius Pollinger, Laura Isigkeit, Pascal Heitel, Astrid Kaiser, Lennart Obeser, Georg Höfner, Ewgenij Proschak, Stefan Knapp, Apirat Chaikuad, Jan Heering & Daniel Merk. (2023) Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation. Journal of the American Chemical Society 145:27, pages 14802-14810.
Crossref
Jia Wang, Lei Wang, Xiao-Jing Zhang, Peng Zhang, Jingjing Cai, Zhi-Gang She & Hongliang Li. (2023) Recent updates on targeting the molecular mediators of NAFLD. Journal of Molecular Medicine 101:1-2, pages 101-124.
Crossref
Lidia Staszewsky & Silvio Garattini. (2022) Scientific and ethical issues in add-on designs for antidiabetic drugs. European Journal of Clinical Pharmacology 78:9, pages 1399-1401.
Crossref
Reetu Reetu, Aakriti Garg, Kuldeep K. Roy, Anupam Roy, Sreya Gupta & Chandi C. Malakar. (2022) In-silico studies for targeting PPARγ for the Type II Diabetes Mellitus. Materials Today: Proceedings 57, pages 44-48.
Crossref
Erick P. Gutiérrez-Grijalva, Laura A. Contreras-Angulo, Alexis Emus-Medina & J. Basilio Heredia. 2021. Structure and Health Effects of Natural Products on Diabetes Mellitus. Structure and Health Effects of Natural Products on Diabetes Mellitus 251 266 .
Tenzin D. Dagpo, Christopher J. Nolan & Viviane Delghingaro-Augusto. (2020) Exploring Therapeutic Targets to Reverse or Prevent the Transition from Metabolically Healthy to Unhealthy Obesity. Cells 9:7, pages 1596.
Crossref
Piotr Mrowka & Eliza Glodkowska-Mrowka. (2020) PPARγ Agonists in Combination Cancer Therapies. Current Cancer Drug Targets 20:3, pages 197-215.
Crossref
Harry G. Preuss, Nate Mrvichin, Gilbert R. Kaats, Jeffrey M. Preuss & Debasis Bagchi. 2020. Dietary Sugar, Salt and Fat in Human Health. Dietary Sugar, Salt and Fat in Human Health 277 289 .
Andrew J. Krentz. 2018. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome 431 454 .
Jenny E. Blau, Sri Harsha Tella, Simeon I. Taylor & Kristina I. Rother. (2017) Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes/Metabolism Research and Reviews 33:8, pages e2924.
Crossref
Andrew J. Krentz & Alan J. Sinclair. 2017. Diabetes in Old Age. Diabetes in Old Age 298 322 .
M. Ruscica, L. Baldessin, D. Boccia, G. Racagni & N. Mitro. (2017) Non-insulin anti-diabetic drugs: An update on pharmacological interactions. Pharmacological Research 115, pages 14-24.
Crossref
Shan Qian, Man Zhang, Yanying He, Wei Wang & Siyan Liu. (2016) Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes. Future Medicinal Chemistry 8:11, pages 1239-1258.
Crossref
Enas A. Abd El-Haleim, Ashraf K. Bahgat & Samira Saleh. (2016) Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression. European Journal of Pharmacology 773, pages 59-70.
Crossref
Damon A. Bell & Gerald F. Watts. (2015) Contemporary and Novel Therapeutic Options for Hypertriglyceridemia. Clinical Therapeutics 37:12, pages 2732-2750.
Crossref
Sascha Sauer. (2015) Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma. Trends in Pharmacological Sciences 36:10, pages 688-704.
Crossref
Jing Yao, WeiJia Kong & JianDong Jiang. (2014) Learning from berberine: Treating chronic diseases through multiple targets. Science China Life Sciences 58:9, pages 854-859.
Crossref
Sandra Barbosa-da-Silva, Vanessa Souza-Mello, D'Angelo Carlo Magliano, Thatiany de Souza Marinho, Marcia Barbosa Aguila & Carlos Alberto Mandarim-de-Lacerda. (2015) Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice. Life Sciences 127, pages 73-81.
Crossref
Bogna Grygiel-Górniak. (2014) Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review. Nutrition Journal 13:1.
Crossref
Amirhossein Sahebkar, Gerard T. Chew & Gerald F. Watts. (2014) Recent advances in pharmacotherapy for hypertriglyceridemia. Progress in Lipid Research 56, pages 47-66.
Crossref
A. Sahebkar & G. F. Watts. (2014) Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: tale of a roller-coaster. Diabetes, Obesity and Metabolism 16:9, pages 780-792.
Crossref
Damien Noone & Christoph Licht. (2013) Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options. Pediatric Nephrology 29:5, pages 779-792.
Crossref
Thing-Fong Tzeng, Chia Ju Chang & I-Min Liu. (2014) 6-Gingerol Inhibits Rosiglitazone-Induced Adipogenesis in 3T3-L1 Adipocytes. Phytotherapy Research 28:2, pages 187-192.
Crossref
A. Consoli & G. Formoso. (2013) Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?. Diabetes, Obesity and Metabolism 15:11, pages 967-977.
Crossref
Marijana Radonjic, Peter Y. Wielinga, Suzan Wopereis, Thomas Kelder, Varshna S. Goelela, Lars Verschuren, Karin Toet, Wim van Duyvenvoorde, Bianca van der Werff van der Vat, Johanna H. M. Stroeve, Nicole Cnubben, Teake Kooistra, Ben van Ommen & Robert Kleemann. (2013) Differential Effects of Drug Interventions and Dietary Lifestyle in Developing Type 2 Diabetes and Complications: A Systems Biology Analysis in LDLr−/− Mice. PLoS ONE 8:2, pages e56122.
Crossref
Feng Zhang, Desong Kong, Yin Lu & Shizhong Zheng. (2012) Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside. Cellular and Molecular Life Sciences 70:2, pages 259-276.
Crossref
John D Imig, Katie A Walsh, Md Abdul Hye Khan, Tasuku Nagasawa, Mary Cherian Shaw, Sean M Shaw & Bruce D Hammock. (2012) Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats. Experimental Biology and Medicine 237:12, pages 1402-1412.
Crossref
J. P. H. Wilding. (2012) PPAR agonists for the treatment of cardiovascular disease in patients with diabetes. Diabetes, Obesity and Metabolism 14:11, pages 973-982.
Crossref
M.W. Laschke & M.D. Menger. (2012) Anti-angiogenic treatment strategies for the therapy of endometriosis. Human Reproduction Update 18:6, pages 682-702.
Crossref
André J. Scheen. (2012) Outcomes and lessons from the PROactive study. Diabetes Research and Clinical Practice 98:2, pages 175-186.
Crossref
Harry G. PreussBobby EchardJia FuNicholas V. PerriconeDebasis BagchiMark KaylorCun Zhuang. (2012) Fraction SX of Maitake Mushroom Favorably Influences Blood Glucose Levels and Blood Pressure in Streptozotocin-Induced Diabetic Rats. Journal of Medicinal Food 15:10, pages 901-908.
Crossref
Philip A CarpinoDeclan Flynn. (2012) Review of companies and drug classes in the 2007–2011 antihypertensive patent literature. Pharmaceutical Patent Analyst 1:1, pages 45-64.
Crossref
Philip A. Carpino & David Hepworth. 2012. Annual Reports in Medicinal Chemistry Volume 47. Annual Reports in Medicinal Chemistry Volume 47 177 192 .
Andrew J. Krentz & Alan J. Sinclair. 2012. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome 459 474 .
S. K. M. Marment, A. J. Semark & P. S. Kruger. 2012. Annual Update in Intensive Care and Emergency Medicine 2012. Annual Update in Intensive Care and Emergency Medicine 2012 138 146 .
Carla Olivares, Analía Ricci, Mariela Bilotas, Rosa Inés Barañao & Gabriela Meresman. (2011) The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis. Fertility and Sterility 96:2, pages 428-433.
Crossref
Stacie B. Dusetzina & G. Caleb Alexander. (2011) Drug vs Class-Specific Black Box Warnings: Does One Bad Drug Spoil the Bunch?. Journal of General Internal Medicine 26:6, pages 570-572.
Crossref
Saroj Niraula & Pamela J. Goodwin. 2011. Insulin Resistance and Cancer. Insulin Resistance and Cancer 269 291 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.